Video
Michael Einodshofer, director, utilization management, Walgreens, describes how contractual methodologies and cost differences across various sites of service can influence how a specialty drug is reimbursed under the medical benefit.
Michael Einodshofer, director, utilization management, Walgreens, describes how contractual methodologies and cost differences across various sites of service can influence how a specialty drug is reimbursed under the medical benefit. Einodshofer explains how to structure benefit design to encourage patients to use the most cost-effective site of service.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa